Discovery of a novel mechanism for the development of co... ( Recent work from the Finnish Academy...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Discovery of a novel mechanism for the development of colon cancer

Date:5/5/2008

Recent work from the Finnish Academy Center of Excellence on Cancer Biology at the University of Helsinki, Finland, has shed light on the mechanisms of colon tumor development and may help to design better treatment for this disease.

Colon cancer is one of the most common malignancies in Western countries: both men and women face a lifetime risk of nearly 6% for the development of invasive colorectal cancer. Epidemiologic studies have shown that several factors contribute to the development of this disease, such as high fat, red-meat diet, obesity and lack of vegetables and fibre in the diet.

In the great majority of cases, colorectal cancer arises from an initially benign overgrowth of colonic lining, a so-called adenomatous polyp (Fig. 1), which acquires with time harmful mutations and transforms into a dangerous colonic carcinoma. Observational studies suggest that the adenoma-to-carcinoma sequence takes up to 10 years. Although nearly half of Western population may harbor adenomatous polyps by the age of 50, it is estimated that only a few percent of adenomas will progress to cancer.

The study published as an advance online publication of Cancer Cell, describe a mechanism by which harmless colon polyps acquire the ability to form malignant tumors. Researchers from the University of Helsinki discovered that PROX1, a protein that in embryos controls formation of normal organs, such as liver or eye, becomes abnormally overproduced at early stages of carcinoma development. PROX1 allows tumor cells to grow even in the absence of stimulating signals from surrounding normal tissues, which leads to dangerous overgrowth and development of advanced tumors.

Removal of PROX1 from cancer cells reverses their malignant behaviour, suggesting that PROX1 is a promising target for the development of future therapies for colon cancer.

'/>"/>

Contact: Kari Alitalo
kari.alitalo@helsinki.fi
358-505-003-572
University of Helsinki
Source:Eurekalert

0

GOOD

Post Your Comments:

(Date:5/21/2013)... Springs, CO (PRWEB) May 22, 2013 ... plan for better nutrition--from farmers' markets filled with whole ... consumers make the most of the season the nutrition ... a healthier lifestyle not to miss. , 1. Eating ... weather that invites shoppers to linger and explore, spring ...

(Date:5/21/2013)... May 21, 2013 Standard advice for ... and little else. However given industry’s less than exceptional ... shoppers via the internet, Consumer Mattress Reports sets out ... Choosing The Best Mattress .” , This article addresses ... and suggestions that may not be readily apparent to ...

(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 Patients ... Dental Care who have lost teeth due to gum disease ... traditional surgery for gum disease treatment with laser gum ... implants, which have the highest success rate out of all ... Procedure (LANAP) is a relatively new procedure cleared by the ...

(Date:5/21/2013)... 21, 2013) Prostaglandin analogues (PGAs), drugs which lower ... for people with glaucoma, but their use is not ... vision, dryness, changes in eye color and other side ... drugs also cause upper and lower eyelid drooping and ... are described in PLOS ONE . , Researchers ...

(Date:5/21/2013)... HealthSmart continues to grow through strategic acquisitions and ... hiring of new talent in several areas, including Account ... Dawn Powell has joined the organization effective April 28, ... Management in the Central Region and is based in ... client management, employee benefits, and product development experience, she ...

Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2 Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3 Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2 Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2 Health News:Glaucoma drug can cause droopy eyelids 2 Health News:New Talent Joins the HealthSmart Account Management Team 2

[0] Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring [0] Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article [0] Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA [0] Glaucoma drug can cause droopy eyelids [0] New Talent Joins the HealthSmart Account Management Team

... of extensive surgery, researchers say , THURSDAY, Aug. 13 (HealthDay ... the extent of early breast cancer may do more harm ... said this use of MRI increases the likelihood that patients ... but that this more aggressive treatment doesn,t lead to improved ...

... , , , ... Inc. (NYSE Amex: KAD ), a leading provider of home care, ... for its fiscal first quarter ended June 30, 2009. , ... revenues of $26.4 million compared with $26.8 million for the same period last ...

... LOS ANGELES, Aug. 13 From cranky bosses to incompetent ... people encounter while making their way through the typical work day ... people up a wall. , , Tanna Marshall, ... 18 years, experience as a natural health practitioner, offers a collection ...

... ... the First in Georgia to Offer Online Records and Direct E-mail Access to Doctors, a ... ... affiliated with Northside Hospital, is leading the way as one of the first physicians’ offices ...

... NES ZIONA, Israel, August 13 Following the ... NanoPass,Technologies Ltd. (NanoPass) announced today that it has successfully,developed ... effectiveness and supply of pandemic flu vaccines. , ... 11th, 2009", said Dr Yotam Levin, the,Company,s CEO, "the ...

... , SEATTLE, Aug. 13 The ... been appointed to head its new European office in London, effective ... health policy and advocacy. , , "Expanding our ... we,re very pleased that Joe will be leading this effort," said ...

MRI May Not Improve Breast Cancer Outcome Arcadia Resources Announces First Quarter Results 'Living Peacefully in a Big City': Natural Health Practitioner Offers Advice on Maintaining Sanity, Health and Happiness Atlanta Women's Specialists Raises the Bar in Patient Care With Online Medical Records and an Electronic Medical Records System NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines Bill & Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office

(Date:5/22/2013)... Calif. , May 22, 2013 Rigel ... the clinical advancement of three programs in development. The ... a JAK/SYK inhibitor, R348, being developed by Rigel as ... programs are aimed at oncology targets and are being ... under development by BerGenBio AS (BerGenBio) and a ligase ...

(Date:5/22/2013)... , May 22, 2013 Assured Pharmacy, Inc. ... prescription medications to sufferers of chronic pain, announced it ... national investor relations firm, to raise its visibility and ... "Over the past year, we have proven our business ... announced plans to open two additional new pharmacies in ...

(Date:5/22/2013)... WomanCare Global recently launched Simplant in ... training initiative attended by 90 health care providers. ... http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) Simplant, a long-acting ... subdermal implant composed of two thin, flexible, silicone ... form of the hormone progestin). These are inserted ...

Breaking Medicine Technology:Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4 Assured Pharmacy Hires Hayden IR 2 Assured Pharmacy Hires Hayden IR 3 WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2

[0] Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye [0] Assured Pharmacy Hires Hayden IR [0] WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile

... 7, 2011 Talyst announces AutoPharm® Mobile, an ... The mobile application can be conveniently accessed on ... efficiency and control across the health system. ... to have real-time access to medication inventory throughout ...

... NEW YORK, Dec. 7, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p098411/Global-Microscopes-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report ... US$ Million by the following Product Segments: ...

Cached Medicine Technology:Talyst Releases AutoPharm Mobile 2 Global Microscopes Industry 2

Talyst Releases AutoPharm Mobile Global Microscopes Industry

... gas permeable contact lenses used for corneal ... nearsightedness (myopia). The patient wears the lenses ... wakening. During the day, nearsightedness is corrected ... Quadra RG contact lenses apply slight pressure ...

... all the major challenges to operating ... fair market fee for each procedure ... licensure requirements., Board Certified Nuclear Medicine ... camera., Hot Lab Equipment and Accessories., ...

... ,Type 330 ,Straight, ,Konan realized an ... illumination between lenses for observation. This ... in ophthalmology and otorhinolaryngology, ,Konan offers ... can; an advanced zoom function (1:3) ...

... and most experienced provider of mobile catheterization ... States. Mobile laboratories serving hospital networks are ... one hospital to another in a particular ... laboratory is fully equipped and operated by ...

Medicine Products:

Paragon Quadra RG (paflufocon B)Nuclear Cardiology Facility Planning Services Operation Microscope Mobile Catheterization Laboratories Serving Hospital Networks